Transthyretin (TTR) Amyloid Cardiomyopathy
7 clinical trials · Condition
◉ Watch Transthyretin (TTR) Amyloid Cardiomyopathy
| Record | Firm | Date |
|---|---|---|
| Vyndaqel Capsules Special Investigation (ATTR-CM) (NCT04108091) | Pfizer | 2019-10-03 |
| PL_GNT01_ISR_Grant 53234273 (NCT06714019) | National Institute of Cardiology, Warsaw, Poland | 2019-02-11 |
| Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy (NCT02791230) | Pfizer | 2016-06-13 |
| Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy (NCT01994889) | Pfizer | 2013-12-09 |
Track Transthyretin (TTR) Amyloid Cardiomyopathy automatically
Every clearance here is in the API, with alerts when new ones post.